Trial Site Detail

 

Drug:
Imatinib
Trial:
Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Institut Bergonie

229 Cours Argonne     
Bordeaux , Gironde 33076
France

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Institut Bergonie Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.